217 related articles for article (PubMed ID: 18615142)
1. L-acetylcarnitine: a proposed therapeutic agent for painful peripheral neuropathies.
Chiechio S; Copani A; Nicoletti F; Gereau RW
Curr Neuropharmacol; 2006 Jul; 4(3):233-7. PubMed ID: 18615142
[TBL] [Abstract][Full Text] [Related]
2. Nutraceutical Approach to Peripheral Neuropathies: Evidence from Clinical Trials.
Mostacci B; Liguori R; Cicero AF
Curr Drug Metab; 2018; 19(5):460-468. PubMed ID: 29086681
[TBL] [Abstract][Full Text] [Related]
3. Specific antinociceptive activity of cholest-4-en-3-one, oxime (TRO19622) in experimental models of painful diabetic and chemotherapy-induced neuropathy.
Bordet T; Buisson B; Michaud M; Abitbol JL; Marchand F; Grist J; Andriambeloson E; Malcangio M; Pruss RM
J Pharmacol Exp Ther; 2008 Aug; 326(2):623-32. PubMed ID: 18492948
[TBL] [Abstract][Full Text] [Related]
4. Elucidation of pathophysiology and treatment of neuropathic pain.
Vranken JH
Cent Nerv Syst Agents Med Chem; 2012 Dec; 12(4):304-14. PubMed ID: 23033930
[TBL] [Abstract][Full Text] [Related]
5. [Botulinum toxin and painful peripheral neuropathies: what should be expected?].
Ranoux D
Rev Neurol (Paris); 2011 Jan; 167(1):46-50. PubMed ID: 21194720
[TBL] [Abstract][Full Text] [Related]
6. Overview on pathophysiology and newer approaches to treatment of peripheral neuropathies.
Vanotti A; Osio M; Mailland E; Nascimbene C; Capiluppi E; Mariani C
CNS Drugs; 2007; 21 Suppl 1():3-12; discussion 45-6. PubMed ID: 17696588
[TBL] [Abstract][Full Text] [Related]
7. Acetyl-L-carnitine: from a biological curiosity to a drug for the peripheral nervous system and beyond.
Onofrj M; Ciccocioppo F; Varanese S; di Muzio A; Calvani M; Chiechio S; Osio M; Thomas A
Expert Rev Neurother; 2013 Aug; 13(8):925-36. PubMed ID: 23965166
[TBL] [Abstract][Full Text] [Related]
8. Acetyl-L-carnitine in neuropathic pain: experimental data.
Chiechio S; Copani A; Gereau RW; Nicoletti F
CNS Drugs; 2007; 21 Suppl 1():31-8; discussion 45-6. PubMed ID: 17696591
[TBL] [Abstract][Full Text] [Related]
9. Painful peripheral neuropathy and its nonsurgical treatment.
Wolfe GI; Trivedi JR
Muscle Nerve; 2004 Jul; 30(1):3-19. PubMed ID: 15221874
[TBL] [Abstract][Full Text] [Related]
10. Analgesia induced by the epigenetic drug, L-acetylcarnitine, outlasts the end of treatment in mouse models of chronic inflammatory and neuropathic pain.
Notartomaso S; Mascio G; Bernabucci M; Zappulla C; Scarselli P; Cannella M; Imbriglio T; Gradini R; Battaglia G; Bruno V; Nicoletti F
Mol Pain; 2017 Jan; 13():1744806917697009. PubMed ID: 28326943
[TBL] [Abstract][Full Text] [Related]
11. Botulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-Rehabilitation.
Intiso D; Basciani M; Santamato A; Intiso M; Di Rienzo F
Toxins (Basel); 2015 Jun; 7(7):2454-80. PubMed ID: 26134256
[TBL] [Abstract][Full Text] [Related]
12. Painful neuropathies.
Sommer C
Curr Opin Neurol; 2003 Oct; 16(5):623-8. PubMed ID: 14501847
[TBL] [Abstract][Full Text] [Related]
13. Treatment of painful peripheral neuropathy.
Wolfe GI; Hotz SE; Barohn RJ
J Clin Neuromuscul Dis; 2002 Dec; 4(2):50-9. PubMed ID: 19078690
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms and treatment of neuropathic pain.
Vranken JH
Cent Nerv Syst Agents Med Chem; 2009 Mar; 9(1):71-8. PubMed ID: 20021340
[TBL] [Abstract][Full Text] [Related]
15. Oxcarbazepine for neuropathic pain.
Zhou M; Chen N; He L; Yang M; Zhu C; Wu F
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD007963. PubMed ID: 29199767
[TBL] [Abstract][Full Text] [Related]
16. An update on the pharmacological management of post-herpetic neuralgia and painful diabetic neuropathy.
Zin CS; Nissen LM; Smith MT; O'Callaghan JP; Moore BJ
CNS Drugs; 2008; 22(5):417-42. PubMed ID: 18399710
[TBL] [Abstract][Full Text] [Related]
17. Thioctic acid and acetyl-L-carnitine in the treatment of sciatic pain caused by a herniated disc: a randomized, double-blind, comparative study.
Memeo A; Loiero M
Clin Drug Investig; 2008; 28(8):495-500. PubMed ID: 18598095
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of a fixed combination of palmitoylethanolamide and acetyl-l-carnitine (PEA+ALC FC) in the treatment of neuropathies secondary to rheumatic diseases.
Parisi S; Ditto MC; Borrelli R; Fusaro E
Minerva Med; 2021 Aug; 112(4):492-499. PubMed ID: 34056884
[TBL] [Abstract][Full Text] [Related]
19. Painful Peripheral Neuropathy.
Wolfe GI; Barohn RJ
Curr Treat Options Neurol; 2002 May; 4(3):177-188. PubMed ID: 11931724
[TBL] [Abstract][Full Text] [Related]
20. L-Acetylcarnitine induces analgesia by selectively up-regulating mGlu2 metabotropic glutamate receptors.
Chiechio S; Caricasole A; Barletta E; Storto M; Catania MV; Copani A; Vertechy M; Nicolai R; Calvani M; Melchiorri D; Nicoletti F
Mol Pharmacol; 2002 May; 61(5):989-96. PubMed ID: 11961116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
